Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
---|
07/06/2000 | CA2356838A1 Imidazole compounds and medicinal use thereof |
07/06/2000 | CA2356748A1 Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia |
07/06/2000 | CA2356671A1 Protease inhibitors |
07/06/2000 | CA2356638A1 Indole and indolizidine derivatives for the treatment of migraine |
07/06/2000 | CA2356606A1 Method of using a cyclooxygenase-2 inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
07/06/2000 | CA2356462A1 Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
07/06/2000 | CA2356459A1 Method of using a matrix metalloproteinase inhibitor and radiation therapy as combination therapy in the treatment of neoplasia |
07/06/2000 | CA2356402A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia |
07/06/2000 | CA2356302A1 Method of using a cyclooxygenase-2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
07/06/2000 | CA2356214A1 Heterocyclic amides as inhibitors of factor xa |
07/06/2000 | CA2355744A1 Novel inhibitors of farnesyl-protein transferase |
07/05/2000 | EP1016661A1 2,6-dichloro-4-pyridinemethanol derivatives and agricultural chemicals |
07/05/2000 | EP1015446A1 (4-piperidinyl)-1h-2-benzopyran derivatives useful as antipsychotic agents |
07/05/2000 | EP1015441A1 Process to produce 4-hydroxy-2-oxo-pyrane derivatives useful as protease inhibitors |
07/05/2000 | EP1014962A1 Antithrombotic agents |
07/05/2000 | EP0882138B1 Stereoselective preparation of 2-substituted succinic derivatives |
07/05/2000 | EP0788490B1 Bisarylcarbinol cinnamic acids as inhibitors of leukotriene biosynthesis |
07/05/2000 | EP0686151B1 Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors |
07/05/2000 | EP0639180B1 Process for stereospecific hydrolysis of piperidinedione derivatives |
07/05/2000 | EP0630367B1 Novel arylindazoles and their use as herbicides |
07/05/2000 | CN1259122A Method for producing chiral 3,4-dehydroprolines |
07/05/2000 | CN1259049A Carboxamides useful as 5-HT1F agonists |
07/05/2000 | CN1258675A Process and intermediate for producing 5-lipoxidase inhibitor |
07/05/2000 | CN1054129C Process for producing 3-arylbenzofuranone |
07/04/2000 | US6083955 Having a high affinity for drugs, especially endoserine receptors |
07/04/2000 | US6083944 Enzyme inhibitors; treatment of various debilitating disorders |
07/04/2000 | US6083881 Pyrazole derivatives as herbicides |
07/04/2000 | CA2116565C Low speed model following velocity command system for rotary wing aircraft |
06/29/2000 | WO2000037473A1 Epothilone derivatives and their use as antitumor agents |
06/29/2000 | WO2000037464A2 4-(aminoalkoxy)benzofurans as n-myristoyltransferase inhibitors |
06/29/2000 | WO2000037463A1 S-oxide lipid lowering compounds |
06/29/2000 | WO2000037462A1 Non-peptide nk1 receptors antagonists |
06/29/2000 | WO2000037461A1 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders |
06/29/2000 | WO2000037458A1 Farnesyl protein transferase inhibitors |
06/29/2000 | WO2000037451A1 Il-5 inhibiting 6-azauracil derivatives |
06/29/2000 | WO2000037436A1 Sulfonamide hydroxamates |
06/29/2000 | WO2000037107A2 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia |
06/29/2000 | WO2000004893A3 Imidazoline receptor binding compounds |
06/29/2000 | DE19859684A1 Verfahren zur Herstellung von Fluor enthaltenden Phenethylaminen sowie neue, Fluor enthalende beta-Iminovinyl- und beta-Iminoethylbenzole A process for preparing fluorine-containing phenethylamines and new, fluorine enthalende beta-iminovinyl- and beta-iminoethylbenzenes |
06/29/2000 | CA2356426A1 Method of using a cyclooxygenase-2 inhibitor and a matrix metalloproteinase inhibitor as a combination therapy in the treatment of neoplasia |
06/29/2000 | CA2355902A1 Sulfonamide hydroxamates |
06/29/2000 | CA2355822A1 S-oxide lipid lowering compounds |
06/29/2000 | CA2355694A1 Novel bicyclic compounds |
06/29/2000 | CA2355137A1 Non-peptide nk1 receptors antagonists |
06/29/2000 | CA2354511A1 Il-5 inhibiting 6-azauracil derivatives |
06/28/2000 | EP1013649A1 Liquid crystal compounds incorporating furan ring, liquid crystal composition and liquid crystal display device |
06/28/2000 | EP1013637A2 Process for the preparation of fluor containing phenethylamines and fluor containing beta-iminovinyl- and beta-iminoethylphenyl compounds |
06/28/2000 | EP1013276A1 Aminoazacycloalkanes as CCR5 modulators |
06/28/2000 | EP1012166A1 1-amino-7-isoquinoline derivatives as serine protease inhibitors |
06/28/2000 | EP1012147A2 O-substituted hydroxycumaranone derivatives as antitumor and antimetastatic agents |
06/28/2000 | EP1012140A1 New amidino derivatives and their use as thrombin inhibitors |
06/28/2000 | EP1011679A1 Use of 2,3,4,5-tetrahydro-1h-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders |
06/28/2000 | EP1011677A1 4-aryl-3-aminoquinoline-2-one derivatives as potassium channel modulators |
06/28/2000 | EP1011663A1 BETA-LACTAM INHIBITORS OF CoA-IT |
06/28/2000 | CN1258301A Antiviral protease inhibitors |
06/28/2000 | CN1258296A Pyridine derivatives and pharmaceutical compositions contg. them |
06/28/2000 | CN1258291A Polymerisable, optically active dioxolane diesters |
06/28/2000 | CN1258289A Substd. 2-benzoyl-cyclohexane-1,3-diones |
06/28/2000 | CN1258277A Cyanoguanidines as cell proliferation inhibitors |
06/28/2000 | CN1258192A Fungicidal mixtures |
06/28/2000 | CN1257864A Imidazoline compound, preparing process thereof and pharmaceutical composition contg. same |
06/28/2000 | CN1257863A Sterically hindered amine compound |
06/28/2000 | CN1053904C N-pyridyl carboxamides and derivs. processes for their preparation and pharmaceutical compositions contg. them |
06/28/2000 | CN1053903C Dihydrobenzofuran derivs., their production and use |
06/27/2000 | US6080873 Fused pyrrolecarboxamides; a new class of GABA brain receptor ligands |
06/27/2000 | US6080860 Urea compound where one of the urea nitrogens is part of an (un)substituted 5 or 6 membered ring and/or the other urea nitrogen is substituted with a 2-cyano-4,5-dialkoxyphenyl group; reacting with electrophile to form a leaving group |
06/27/2000 | US6080855 2-isocephem and oxacephem derivatives and use as antibacterial agents |
06/27/2000 | US6080775 Plant safening agent; preferably used as fungicide |
06/27/2000 | US6080763 Inhibit the release of inflammatory cytokines, e.g., tumor necrosis factor and interleukin-1; useful to treat chronic inflammatory disease; autoimmune diseases, e.g. rheumatoid arthritis, osteoporosis; pyrazolylureas |
06/27/2000 | US6080759 Paroxetine hydrochloride anhydrate substantially free of bound organic solvent prepared by displacing the solvent with a displacing agent; substantially free of propan-2-ol such that it is other than form z; antidepressants |
06/27/2000 | US6080757 Treatment of helicobacter (campylobacter) pylori infections; treatment and prevention of peptic ulcers, gastritis, dyspepsia, and gastric cancer |
06/27/2000 | US6080750 For prophylaxis and treatment of diseases caused by infection by rotavirus |
06/27/2000 | US6080749 For controlling fungus pests |
06/27/2000 | US6080745 For treating or preventing disorders of dopamine system, such as schizophrenia |
06/27/2000 | US6080743 2,3-dioxo-1,2,3,4-tetrahydro-quinoxalinyl derivatives |
06/27/2000 | CA2188427C Neurotransmitter release enhancers |
06/27/2000 | CA2017193C N-(aryloxyalkyl)heteroarylpiperidines and-heteroarylpiperazines, a pro cess for their preparation and their use as medicaments |
06/27/2000 | CA2013960C Substituted dibenzofurans and methods of using same |
06/27/2000 | CA2011448C 6-amino-6-desoxyfumagillols, production and use thereof |
06/27/2000 | CA2011169C Composition stabilized with substituted 1,2,4-triazoles |
06/23/2000 | CA2292851A1 Process for preparing fluorine-containing phenethylamines and novel fluorine-containing .beta.-iminovinyl-and .beta.-iminoethylbenzenes |
06/22/2000 | WO2000035915A1 Piperazine derivatives |
06/22/2000 | WO2000035911A1 Heteroaryl-cyclic acetals |
06/22/2000 | WO2000035910A1 Derivative of paroxetine |
06/22/2000 | WO2000035909A1 4-aryloxindoles as inhibitors of jnk protein kinases |
06/22/2000 | WO2000035908A1 4-alkenyl (and alkynyl) oxindoles as inhibitors of cyclin-dependent kinases, in particular cdk2 |
06/22/2000 | WO2000035907A1 Imidazolones and their use in treating benign prostatic hyperplasia and other disorders |
06/22/2000 | WO2000035906A2 4- and 5-alkynyloxindoles and 4- and 5-alkenyloxindoles |
06/22/2000 | WO2000035901A1 Chroman derivatives |
06/22/2000 | WO2000035886A2 (hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors |
06/22/2000 | WO2000035877A1 Heterocyclic piperidines as modulators of chemokine receptor activity |
06/22/2000 | WO2000035875A1 Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine urea derivatives having 5ht1a receptor activity |
06/22/2000 | WO2000035873A1 Process for preparation of paroxetine maleate |
06/22/2000 | WO2000035869A1 New amidino derivatives and their use as thrombin inhibitors |
06/22/2000 | WO2000035859A1 Substituted aryl and heteroaryl derivatives, their production and their use as medicines |
06/22/2000 | WO2000035454A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
06/22/2000 | WO2000035453A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
06/22/2000 | WO2000035452A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
06/22/2000 | WO2000035451A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
06/22/2000 | WO2000035449A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |